<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">9200608</journal-id>
<journal-id journal-id-type="pubmed-jr-id">2299</journal-id>
<journal-id journal-id-type="nlm-ta">Cancer Epidemiol Biomarkers Prev</journal-id>
<journal-id journal-id-type="iso-abbrev">Cancer Epidemiol. Biomarkers Prev.</journal-id>
<journal-title-group>
<journal-title>Cancer epidemiology, biomarkers &amp; prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1055-9965</issn>
<issn pub-type="epub">1538-7755</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28710076</article-id>
<article-id pub-id-type="pmc">5581729</article-id>
<article-id pub-id-type="doi">10.1158/1055-9965.EPI-17-0459</article-id>
<article-id pub-id-type="manuscript">NIHMS889651</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Opportunities and Challenges for Environmental Exposure Assessment in Population-Based Studies</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Patel</surname>
<given-names>Chirag J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kerr</surname>
<given-names>Jacqueline</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Thomas</surname>
<given-names>Duncan C.</given-names>
</name>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mukherjee</surname>
<given-names>Bhramar</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ritz</surname>
<given-names>Beate</given-names>
</name>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chatterjee</surname>
<given-names>Nilanjan</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jankowska</surname>
<given-names>Marta</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Madan</surname>
<given-names>Juliette</given-names>
</name>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Karagas</surname>
<given-names>Margaret R.</given-names>
</name>
<xref ref-type="aff" rid="A8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McAllister</surname>
<given-names>Kimberly A.</given-names>
</name>
<xref ref-type="aff" rid="A9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Mechanic</surname>
<given-names>Leah E.</given-names>
</name>
<xref ref-type="aff" rid="A10">10</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fallin</surname>
<given-names>M. Daniele</given-names>
</name>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ladd-Acosta</surname>
<given-names>Christine</given-names>
</name>
<xref ref-type="aff" rid="A11">11</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Blair</surname>
<given-names>Ian A.</given-names>
</name>
<xref ref-type="aff" rid="A12">12</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Teitelbaum</surname>
<given-names>Susan L.</given-names>
</name>
<xref ref-type="aff" rid="A13">13</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Amos</surname>
<given-names>Christopher I.</given-names>
</name>
<xref ref-type="aff" rid="A14">14</xref>
</contrib>
</contrib-group>
<aff id="A1">
<label>1</label>Department of Biomedical Informatics, Harvard Medical School, 10 Shattuck St, Boston, MA, 02115</aff>
<aff id="A2">
<label>2</label>Department of Family Medicine and Public Health, University of California San Diego, La Jolla, CA 92093</aff>
<aff id="A3">
<label>3</label>Department of Preventive Medicine, University of Southern California, Los Angeles, CA 90032</aff>
<aff id="A4">
<label>4</label>Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI 48109</aff>
<aff id="A5">
<label>5</label>Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, 90095</aff>
<aff id="A6">
<label>6</label>Department of Biostatistics and Department of Oncology, Johns Hopkins University, Baltimore, MD 21205</aff>
<aff id="A7">
<label>7</label>Division of Neonatology, Department of Pediatrics, Dartmouth-Hitchcock Medical Center, Lebanon, NH 03755</aff>
<aff id="A8">
<label>8</label>Department of Epidemiology, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03755</aff>
<aff id="A9">
<label>9</label>Susceptibility and Population Health Branch, National Institute of Environmental Health Sciences, NIH, Research Triangle Park, NC 27709</aff>
<aff id="A10">
<label>10</label>Epidemiology and Genomics Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, NIH, Bethesda, MD 20892</aff>
<aff id="A11">
<label>11</label>Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD 21205</aff>
<aff id="A12">
<label>12</label>Center of Excellence in Environmental Toxicology and Penn SRP Center, Perelman School of Medicine, University of Pennsylvania Philadelphia, PA 19104, United States; Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania Philadelphia, PA 19104</aff>
<aff id="A13">
<label>13</label>Department of Preventive Medicine, Icahn School of Medicine at Mount Sinai, New York, NY 10029</aff>
<aff id="A14">
<label>14</label>Department of Biomedical Data Science,, Geisel School of Medicine at Dartmouth College, Lebanon, NH 03755</aff>
<author-notes>
<corresp id="FN1">Corresponding Authors: Chirag Patel, 10 Shattuck St, Boston, MA. 02115, 617 432 1195, <email>chirag_patel@hms.harvard.edu</email>. Christopher Amos, Williamson Translational Building - 3, 1 Medical Center Drive, Lebanon NH 03756, <email>Christopher.I.Amos@Dartmouth.edu</email></corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>4</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="epub">
<day>14</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>01</day>
<month>9</month>
<year>2018</year>
</pub-date>
<volume>26</volume>
<issue>9</issue>
<fpage>1370</fpage>
<lpage>1380</lpage>
<!--elocation-id from pubmed: 10.1158/1055-9965.EPI-17-0459-->
<abstract>
<sec id="S1">
<title>Background</title>
<p id="P1">A growing number and increasing diversity of factors are available for epidemiological studies. These measures provide new avenues for discovery and prevention yet they also raise many challenges for adoption in epidemiological investigations.</p>
</sec>
<sec id="S2">
<title>Methods</title>
<p id="P2">We evaluate 1) designs to investigate diseases that consider heterogeneous and multi-dimensional indicators of exposure and behavior, 2) the implementation of numerous methods to capture indicators of exposure, and 3) the analytical methods required for discovery and validation.</p>
</sec>
<sec id="S3">
<title>Results</title>
<p id="P3">Case-control studies have provided insights into genetic susceptibility but are insufficient for characterizing complex effects of environmental factors on disease development. Prospective designs are required but must balance extended data collection with follow-up of study participants. Two phase designs are described. We discuss innovations in assessments including the microbiome, mass spectrometry and metabolomics, behavioral assessment, dietary, physical activity and occupational exposure assessment, air pollution monitoring and global positioning and individual sensors. The availability of extensive correlated data raises new challenges in disentangling specific exposures that influence cancer risk from among extensive and often correlated exposures.</p>
</sec>
<sec id="S4">
<title>Conclusions</title>
<p id="P4">New exposure assessments offer many new opportunities for environmental assessment in cancer development.</p>
</sec>
<sec id="S5">
<title>Impact</title>
<p id="P5">We describe and evaluate the state of the art for evaluating high dimensional environmental studies.</p>
</sec>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>